Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis

J Med Toxicol. 2022 Jan;18(1):63-64. doi: 10.1007/s13181-021-00851-6. Epub 2021 Jul 5.

Authors

Demis N Lipe¹, Nicolas L Palaskas², Patrick Chaftari³

Affiliations

¹ Department of Emergency Medicine, Unit 1468, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA. DNLipe@mdanderson.org.
² Department of Cardiology, Unit 1451, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
³ Department of Emergency Medicine, Unit 1468, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, 77030, USA.

No abstract available

Keywords: Cardiotoxicity; Immune checkpoint inhibitors; irAEs, emergency department.

Publication types

Letter
Comment

MeSH terms

Cardiotoxicity
Humans
Immune Checkpoint Inhibitors*
Myocarditis* / chemically induced

Substances

Immune Checkpoint Inhibitors